Celldex Therapeutics reported $-83.58M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
AbbVie USD 5.37B 1.85B Dec/2025
Agenus USD -10.11M 19.02M Mar/2025
Amgen USD 5.14B 775M Dec/2025
Bristol-Myers Squibb USD 2.88B 1.36B Dec/2025
Celldex Therapeutics USD -83.58M 2.76M Mar/2026
Glaxosmithkline GBP 4.75B 1.52B Sep/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Northwest Biotherapeutics USD -13.41M 232K Sep/2023
Pfizer USD 5.99B 5.23B Mar/2026
Rigel Pharmaceuticals USD -4.17M 798K Sep/2023
Roche Holding CHF 12.68B 2.36B Jun/2024